Skip to content

Evaluation of early carotid atherosclerosis development in a healthy population based on plasma levels of associated-antibodies: a cross-sectional study

Early evaluation of carotid atherosclerosis from blood antibodies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089577
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid atherosclerosis

Interventions

Non-carotid atherosclerosis:Not application
carotid intima-media thickening:Not application
carotid plaque formation:carotid plaque formation

Sponsors

The First Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Individuals undergoing a health checkup with carotid ultrasound as part of the examination itinerary. 2.Serum sample remained after the routine blood test collected on the same day. 3.Serum samples aliquoted and stored in a -80 degree Celsius freezer. 4.Voluntary participation in clinical research, with signed informed consent in physical screening for health promotion program.

Exclusion criteria

Exclusion criteria: 1.Possibly broken or contaminated serum sample affecting experimental results. 2.Diagnosed atherosclerosis cardiovascular diseases (i.e, coronary artery disease, stoke) . 3.Conditions judged by the investigator to be unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
serum anti-H2b level;

Secondary

MeasureTime frame
Blood low-density lipoprotein cholesterol level;

Countries

China

Contacts

Public ContactWang Yan

The First Affiliated Hospital, Sun Yat-sen University

wangy68@mail.sysu.edu.cn+86 135 3997 6984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026